No abstract is available for this article.

Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy / Brioli A;Boyd KD;Kaiser MF;Pawlyn C;Wu P;Gregory WM;Owen R;Ross FM;Jackson GH;Cavo M;Davies FE;Morgan GJ. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 161:(2013), pp. 291-294. [10.1111/bjh.12218]

Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy.

BRIOLI, ANNAMARIA;CAVO, MICHELE;
2013

Abstract

No abstract is available for this article.
2013
Response and biological subtype of myeloma are independent prognostic factors and combine to define outcome after high-dose therapy / Brioli A;Boyd KD;Kaiser MF;Pawlyn C;Wu P;Gregory WM;Owen R;Ross FM;Jackson GH;Cavo M;Davies FE;Morgan GJ. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - STAMPA. - 161:(2013), pp. 291-294. [10.1111/bjh.12218]
Brioli A;Boyd KD;Kaiser MF;Pawlyn C;Wu P;Gregory WM;Owen R;Ross FM;Jackson GH;Cavo M;Davies FE;Morgan GJ
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/395993
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact